0001127602-21-018165.txt : 20210527 0001127602-21-018165.hdr.sgml : 20210527 20210527160448 ACCESSION NUMBER: 0001127602-21-018165 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210525 FILED AS OF DATE: 20210527 DATE AS OF CHANGE: 20210527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HENDERSON LORI M. CENTRAL INDEX KEY: 0001221127 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 21972623 MAIL ADDRESS: STREET 1: MOLDFLOW CORP STREET 2: 430 BOSTON POST ROAD CITY: WAYLAND STATE: MA ZIP: 01778 FORMER NAME: FORMER CONFORMED NAME: HENDERSON LORI M DATE OF NAME CHANGE: 20030228 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-05-25 0001682852 Moderna, Inc. MRNA 0001221127 HENDERSON LORI M. C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 General Counsel and Secretary Common Stock 2021-05-25 4 M 0 6600 14.85 A 7501 D Common Stock 2021-05-25 4 S 0 6600 166.58 D 901 D Stock Option (Right to Buy) 14.85 2021-05-25 4 M 0 6600 0 D 2028-06-26 Common Stock 6600 334952 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2020. 25% of this option will vest and become exercisable on April 9, 2019 with the remainder vesting in 12 equal quarterly installments thereafter. /s/ Brian Sandstrom, as Attorney-in-Fact 2021-05-27